
Henry Schein (HSIC) | Stock Overview & Key Data
Henry Schein Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $92.68 on April 11, 2022
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Peer Performance Comparison
Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
---|---|---|---|---|---|---|---|---|---|
Henry Schein HSIC | 8.22B Mid-cap | 0.44% | -1.25% | -5.37% | -11.69% | -0.50% | -3.69% | -7.06% | 2.66% |
McKesson MCK | 84.20B Large-cap | 4.78% | -0.73% | -1.77% | 18.12% | 24.69% | 27.86% | 97.88% | 358.83% |
Cencora COR | 56.66B Large-cap | 2.84% | 3.61% | 4.07% | 25.60% | 34.92% | 27.55% | 107.42% | 210.85% |
Patterson Companies PDCO | 2.77B Mid-cap | -0.03% | 0.55% | 1.23% | 47.16% | 1.72% | 21.58% | 1.82% | 87.72% |
Cardinal Health CAH | 35.73B Large-cap | 0.90% | -4.42% | -1.13% | 19.29% | 28.43% | 38.50% | 124.22% | 200.14% |
Owens & Minor OMI | 408.62M Small-cap | -5.93% | -34.37% | -26.06% | -18.33% | -60.47% | -68.97% | -83.26% | -69.31% |
Ownership & Short Interest
Henry Schein Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Henry Schein would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is HSIC's 52-week high and low?
- In the last 52 weeks, Henry Schein reached a high of $82.49 (on February 5, 2025) and a low of $60.56 (on April 9, 2025).
- What is the market cap and P/E ratio for HSIC?
- Curious about Henry Schein's size and valuation? Its market capitalization stands at 8.22B. When it comes to valuation, the P/E ratio (trailing twelve months) is 21.79, and the forward P/E (looking ahead) is 13.03.
- Does HSIC pay dividends? If so, what's the yield?
- As for dividends, Henry Schein isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Henry Schein's main competitors or similar companies to consider before investing?
When looking at Henry Schein, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return McKesson
MCK84.20B Healthcare Medical Distribution 27.86% 97.88% Cencora
COR56.66B Healthcare Medical Distribution 27.55% 107.42% Patterson Companies
PDCO2.77B Healthcare Medical Distribution 21.58% 1.82% Cardinal Health
CAH35.73B Healthcare Medical Distribution 38.50% 124.22% Owens & Minor
OMI408.62M Healthcare Medical Distribution -68.97% -83.26% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Henry Schein Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Henry Schein's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 8.12%, the Debt to Equity ratio from the most recent quarter is 68.55, and its Gross Profit Margin stands at 31.36%.
- What is the recent revenue and earnings growth for HSIC?
- Looking at Henry Schein's growth, its revenue over the trailing twelve months (TTM) was $13B. Compared to the same quarter last year (YoY), quarterly revenue grew by 3.30%, and quarterly earnings saw a YoY growth of -17.30%.
- How much of HSIC stock is held by insiders and institutions?
- Wondering who owns Henry Schein stock? Company insiders (like executives and directors) hold about 0.87% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 113.71%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.